Premium
Hypertension treatment – why aren't we doing better?
Author(s) -
Lewis Philip
Publication year - 2014
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1242
Subject(s) - citation , medicine , library science , computer science
adequate control to a majority of patients with hypertension in the UK. Between 1994 and 2011, Health Surveys for England have shown the prevalence of hypertension has remained stable at 32 per cent, with progressive improvements in hypertension patients being aware of their diagnosis (71 per cent), in being treated (58 per cent) and having blood pressure adequately controlled (37 per cent). However, among treated hypertension patients, only 20 per cent of those with a 10-year cardiovascular risk of ≥20 per cent had blood pressure <140/90mmHg compared with 65 per cent with a self-reported history of cardiovascular disease and 57 per cent with type 2 diabetes.1 The cost of inadequate control has been demonstrated recently in a 1.25 million patient cohort study in which, from the age of 30 years, hypertension was associated with a 37.3 per cent greater lifetime risk of developing cardiovascular disease, occurring on average five years earlier than in normotensive patients.2